SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (18082)1/24/1999 11:32:00 AM
From: Greg22  Read Replies (1) of 23519
 
<<Current analyst's consensus estimates in FY1999 of +0.36 IMO are way too low. I believe Vivus will be able to show earnings in 1999 of at least +0.70. >>

I could not agree with you more (If you include milestones, it will probably exceed a buck). But one thing management has learned throughout this entire ordeal is that when a small biotech misses earnings, stock price is punished with a vengeance.

Vivus is on the road to recovery. I think it is very wise for Leland to plan for the worst case scenario, and then some. Clearly with EPS of +0.36 he has done just that; Vivus is ready for the unexpected. What if everything goes better than the +0.36? Than the worst thing that can happen is an analyst upgrade and an increase in stock price. Can't lose.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext